I just read in our MSW weekly newsletter that Sandoz, a Novartis company, today announced the US launch of GlatopaTM, the first generic version of Teva's Copaxone® (glatiramer acetate injection) 20 mg/ml one-time-daily multiple sclerosis therapy.

In case you missed it, read more here - https://www.novartis.com/news/media-...one%C2%AE-20mg